Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

102.400
+1.2001.19%
Volume:15.25M
Turnover:1.56B
Market Cap:178.59B
PE:186.71
High:104.000
Open:101.800
Low:100.600
Close:101.200
52wk High:109.100
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:1.10
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:5.01%
ROA:1.56%
PB:7.91
PE(LYR):186.71
PS:11.74

Loading ...

Movement Alert|INNOVENT BIO Rises 4.43% in Regular Trading, Morgan Stanley Raises Target Price to HK$138.5 Amid Strong H1 Revenue Expectations

Market Focus
·
Aug 20

Movement Alert|INNOVENT BIO Rises 3.47% in Regular Trading, BlackRock Stake Increase and Strong H1 Revenue Fuel Optimism

Market Focus
·
Aug 19

Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?

Simply Wall St.
·
Aug 19

BlackRock Expands Stake in INNOVENT BIO with Recent Share Purchase

Stock News
·
Aug 17

Movement Alert|INNOVENT BIO Rises 3.78% in Regular Trading, Strong H1 Performance and New Retail Channel Expansion Fuel Optimism

Market Focus
·
Aug 17

Spero Q2 FY26 Net Loss Widens to $9.6 Million; Revenue Posts no Revenue

Reuters
·
Aug 13

Innovent Biologics Schedules 25 Aug 2026 Board Meeting to Approve 1H26 Results

Bulletin Express
·
Aug 10

Innovent Biologics Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 10

Innovent Biologics Slashes Prices on Weight-Loss Drug as Growth Concerns Mount

Deep News
·
Aug 10

Movement Alert|INNOVENT BIO Rises 3.06% in Regular Trading, H1 Revenue Significantly Beats Expectations as Multiple Banks Raise Target Prices

Market Focus
·
Aug 10

Innovent Biologics Signs Exclusive Deal with Daiichi Sankyo to Commercialize Vanflyta in China

Reuters
·
Aug 10

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

Movement Alert|INNOVENT BIO Rises 3.02% in Regular Trading, Multiple Banks Raise Target Prices on Strong Revenue Beat and Pipeline Progress

Market Focus
·
Aug 07

Goldman Sachs Lifts INNOVENT BIO Target to HKD 111.68 on Strong H1 Product Revenue Growth

Stock News
·
Aug 06

Innovent Announces First Patient Dosed in Pivotal Registrational Study of Ibi363/Tak-928 (Pd-1/Il-2Α-Biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

THOMSON REUTERS
·
Aug 06

Citigroup Maintains Bullish Stance on INNOVENT BIO with HK$115 Price Target

Deep News
·
Aug 05

CLSA: INNOVENT BIO (01801) First-Half Product Revenue Significantly Exceeds Expectations, Serving as a Positive Catalyst for Stock Price

Stock News
·
Aug 05

Innovent Biologics' Product Revenue Surges 60% in Q2

MT Newswires Live
·
Aug 05

Innovent Biologics Jumps Most in 3 Weeks on Robust Product Revenue Growth

Reuters
·
Aug 05

INNOVENT BIO shares open over 2% higher as first-half product revenue exceeds RMB 8.2 billion, marking a 55% surge

Stock News
·
Aug 05